Display options
Share it on

Intractable Rare Dis Res. 2021 Aug;10(3):207-213. doi: 10.5582/irdr.2021.01047.

Familial SDHB gene mutation in disseminated non-hypoxia-related malignant paraganglioma treated with [.

Intractable & rare diseases research

Izabela Łoń, Jolanta Kunikowska, Piotr Jędrusik, Jarosław Góra, Sadegh Toutounchi, Grzegorz Placha, Zbigniew Gaciong

Affiliations

  1. Department of Internal Medicine, Hypertension and Vascular Diseases, Medical University of Warsaw, Warsaw, Poland.
  2. Department of Nuclear Medicine, Medical University of Warsaw, Warsaw, Poland.
  3. Department of General and Endocrine Surgery, Medical University of Warsaw, Warsaw, Poland.

PMID: 34466344 PMCID: PMC8397825 DOI: 10.5582/irdr.2021.01047

Abstract

Familial paraganglioma may be related to mutations in succinate dehydrogenase (SDH) enzyme complex genes. Among patients with hereditary paraganglioma, SDH subunit B (SDHB) gene mutations are associated with the highest morbidity and mortality related to a higher malignancy rate. We report a family with the c.689G>A (p.Arg230His) mutation in the SDHB gene identified in two family members, a father and his daughter. While the 14-year-old daughter had no evidence of clinical disease, recurrent and later disseminated [

2021, International Research and Cooperation Association for Bio & Socio - Sciences Advancement.

Keywords: catecholamine-producing tumor; positron emission tomography/computed tomography; somatostatin receptor imaging; succinate dehydrogenase

Conflict of interest statement

The authors have no conflicts of interest to disclose.

References

  1. Ann N Y Acad Sci. 2006 Aug;1073:405-16 - PubMed
  2. Surgery. 2011 Dec;150(6):1186-93 - PubMed
  3. Cancer Cell. 2005 Jan;7(1):77-85 - PubMed
  4. Hum Pathol. 1973 Jun;4(2):251-63 - PubMed
  5. J Natl Cancer Inst. 2013 Sep 4;105(17):1270-83 - PubMed
  6. J Clin Oncol. 2006 Jan 20;24(3):401-6 - PubMed
  7. Curr Opin Endocrinol Diabetes Obes. 2013 Jun;20(3):186-91 - PubMed
  8. Clin Cancer Res. 2010 Aug 15;16(16):4148-54 - PubMed
  9. Ann Surg Oncol. 2013 May;20(5):1444-50 - PubMed
  10. Cancer. 2012 Jun 1;118(11):2804-12 - PubMed
  11. J Clin Endocrinol Metab. 2014 Jun;99(6):1915-42 - PubMed
  12. Hum Mol Genet. 2005 Aug 1;14(15):2231-9 - PubMed
  13. Eur J Nucl Med Mol Imaging. 2012 Dec;39(12):1977-95 - PubMed
  14. J Clin Endocrinol Metab. 2015 May;100(5):E710-9 - PubMed
  15. Clin Endocrinol (Oxf). 2019 Dec;91(6):718-727 - PubMed
  16. Cancer. 2008 Oct 15;113(8):2020-8 - PubMed
  17. Arch Endocrinol Metab. 2019 Jul 29;63(4):369-375 - PubMed
  18. Int J Urol. 2007 Mar;14(3):181-5 - PubMed
  19. Nucl Med Mol Imaging. 2015 Sep;49(3):223-30 - PubMed
  20. Nucl Med Commun. 2006 Jan;27(1):31-6 - PubMed
  21. Nucl Med Mol Imaging. 2019 Jun;53(3):223-230 - PubMed
  22. Int J Cancer. 2014 Dec 1;135(11):2711-20 - PubMed
  23. J Med Genet. 2018 Jun;55(6):384-394 - PubMed
  24. Pancreas. 2010 Aug;39(6):775-83 - PubMed
  25. J Clin Endocrinol Metab. 2015 Apr;100(4):1325-34 - PubMed
  26. Front Endocrinol (Lausanne). 2020 Feb 18;11:61 - PubMed
  27. Eur J Endocrinol. 2019 Jul;181(1):45-53 - PubMed
  28. J Clin Endocrinol Metab. 2009 May;94(5):1541-7 - PubMed
  29. J Clin Endocrinol Metab. 2009 Aug;94(8):2817-27 - PubMed
  30. Eur J Endocrinol. 2012 Jun;166(6):1107-11 - PubMed

Publication Types